(6-Chloro-4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)(4-hydroxypiperidin-1-yl)methanone

ID: ALA4096333

PubChem CID: 135198767

Max Phase: Preclinical

Molecular Formula: C18H19ClN6O2

Molecular Weight: 386.84

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(Nc2nc(C(=O)N3CCC(O)CC3)nc3ccc(Cl)cc23)n[nH]1

Standard InChI:  InChI=1S/C18H19ClN6O2/c1-10-8-15(24-23-10)21-16-13-9-11(19)2-3-14(13)20-17(22-16)18(27)25-6-4-12(26)5-7-25/h2-3,8-9,12,26H,4-7H2,1H3,(H2,20,21,22,23,24)

Standard InChI Key:  KPCXPTZRDANCFF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.7803  -12.5123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4899  -12.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4871  -11.2802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7785  -10.8749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0722  -12.1033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0745  -11.2856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3686  -10.8765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6599  -11.2841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6616  -12.1050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3681  -12.5103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9521  -10.8756    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7750  -10.0578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4809   -9.6461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2263   -9.9732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7705   -9.3636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3588   -8.6576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5603   -8.8310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5836   -9.4455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1983  -12.5104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1996  -13.3275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9053  -12.1006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6120  -12.5138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3170  -12.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3199  -11.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6117  -10.8803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9006  -11.2882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0285  -10.8830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
  8 11  1  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 13  2  0
 15 18  1  0
  2 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4096333

    ---

Associated Targets(Human)

PAK4 Tchem Serine/threonine-protein kinase PAK 4 (3212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.84Molecular Weight (Monoisotopic): 386.1258AlogP: 2.66#Rotatable Bonds: 3
Polar Surface Area: 107.03Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.23CX Basic pKa: 3.12CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.64Np Likeness Score: -1.45

References

1. Hao C, Zhao F, Song H, Guo J, Li X, Jiang X, Huan R, Song S, Zhang Q, Wang R, Wang K, Pang Y, Liu T, Lu T, Huang W, Wang J, Lin B, He Z, Li H, Li F, Zhao D, Cheng M..  (2018)  Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors.,  61  (1): [PMID:29190083] [10.1021/acs.jmedchem.7b01342]

Source